Telomere longitudinal shortening as a biomarker for dementia status of adults with Down syndrome

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 171, Issue 2, 2016, Pages 169-174

  Jenkins, Edmund C ^a   Ye, Lingling ^a   Krinsky Mchale, Sharon J ^a   Zigman, Warren B ^a   Schupf, Nicole ^a,b   Silverman, Wayne P ^c  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Dementia status; Down syndrome; FISH with PNA (peptide nucleic acid) probes; Mild cognitive impairment (MCI); Telomere length in light intensity units; Telomere length in microns; Telomere longitudinal shortening

Indexed keywords

PEPTIDE NUCLEIC ACID; BIOLOGICAL MARKER;

ADULT; ALZHEIMER DISEASE; ARTICLE; CENTROMERE; CHROMOSOME 2; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DOWN SYNDROME; FEMALE; HUMAN; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; TELOMERE SHORTENING; COMPLICATION; GENETICS; METABOLISM; METAPHASE; T LYMPHOCYTE;

ADULT; BIOMARKERS; DEMENTIA; DOWN SYNDROME; FEMALE; HUMANS; MALE; METAPHASE; MIDDLE AGED; T-LYMPHOCYTES; TELOMERE SHORTENING;

EID: 84958150628     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32389     Document Type: Article

References (43)

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. 2011. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimer's Dement 2011 May 7(3):270-279.
2. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CS, Harley CG. 1992. Telomere telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89(21):10114-10118.
3. Cai Z, Yan L-J, Ratka A. 2013. Telomere shortening and Alzheimer's disease. Neuromol Med 15:25-38.
4. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. 2004. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101(49):17312-17315.
5. Flanary BE, Streit WJ. 2003. Telomeres shorten with age in rat cerebellum and cortex in vivo. Anti-Aging Med 6:299-308.
6. Fraser J, Mitchell A. 1876. Kalmuc idiocy: Report of a case with autopsy with notes on sixty-two cases. J Ment Sci 22:169-179.
7. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC. 1987. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 2235(491):877-880.
8. Gruszecka A, Przemyslaw I, Cudzilo D, Lipinska N, Romaniuk A, Barczak W, Rozwadowska N, Toton E, Rubis B. 2015. Telomere shortening in Down syndrome patients-When does it start? DNA Cell Biol 34(6):1-6.
9. Hao LY, Strong MA, Greider CW. 2004. Phosphorylation of H2AX at short telomeres in T cells and fibroblasts. J Biol Chem 269:45148-45154.
10. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. 2014. Leucocyte telomere length and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ 349:g4227.
11. Honig LS, Kang MS, Schupf N, Lee JH, Naueux R. 2012. Association of shorter leukocyte telomere repeat length with dementia and mortality. Arch Neurol 69(10):1332-1339.
12. Horvath S, Garagnani P, Bacalini MG, Pirazzini C, Salvioli S, Gentilini D, Di Blasio AM, Giuliana C, Tung S, Winters HV, Franceschi C. 2015. Accelerated epigenetic aging in Down syndrome. Aging Cell 14:491-495.
13. Jenkins EC, Velinov MT, Ye L, Gu H, Li S, Jenkins EC, Jr, Sklower Brooks S, Pang D, Devenny DA, Zigman WB, Schupf N, Silverman WP. 2006. Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol Aging 27:941-945.
14. Jenkins EC, Ye L, Gu H, Ni SA, Duncan CJ, Velinov M, Pang D, Krinsky-McHale SJ, Zigman WB, Schupf N, Silverman WP. 2008. Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome. Neurosci Lett 440:340-343.
15. Jenkins EC, Ye L, Gu H, Ni SA, Velinov M, Pang D, Krinsky-McHale SJ, Zigman WB, Schupf N, Silverman WP. 2010. Shorter telomeres may indicate dementia status in older individuals with Down syndrome. Neurobiol Aging 31:765-771.
16. Jenkins EC, Ye L, Silverman WP. 2012a. Does the cryogenic freezing process cause shorter telomeres? Cryobiol 65:72-73.
17. Jenkins EC, Ye L, Gu H, Velinov M, Krinsky-McHale SJ, Zigman WB, Schupf N, Silverman WP. 2012b. Mild cognitive impairment identified in older individuals with Down syndrome by reduced telomere signal numbers and shorter telomeres measured in microns. Am J Med Genet Part B 159B:598-604.
18. Jervis GA. 1948. Early senile dementia in mongoloid idiocy. Am J Psychiatry 105(2):102-106.
19. Keeling B, Antia C, Steadmon M, Wesson S, Williams C. 2014. Dyskeratosis congenita. Dermatol Online J 2014 Sep 16; 20(9). Pii: http://www.escholarshipo.org/uc/item/3rg5c153.
20. Krinsky-McHale SJ, Silverman W. 2013. Dementia and mild cognitive impairment in adults with intellectual disability: Issues of diagnosis. Dev Disabil Res Rev 191:31-42.
21. Lansdorp PM, Verwoerd NP, van de Rujke FM, Dragowska V, Little M-T, Dirks RW, Raap AK, Tanke HJ. 1996. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5:685-691.
22. Leverenz JB, Raskind MA. 1998. Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: A regional quantitative analysis. Exp Neurol 150(2):296-304.
23. Londono-Vallejo JA, DerSarkissian H, Cazes L, Thomas G. 2001. Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res 29:3164-3171.
24. Malamud N. 1972. Neuropathology of organic brain syndrome associated with aging. In: Gatz CG, editor. Aging and the Brain. New York: Plenum. pp 67-87.
25. Mathur S, Ardestani A, Parker B, Cappizzi J, Polk D, Thompson PD. 2013. Telomere length and cardiorespiratory fitness in marathon runners. J Investig Med 61(3):613-615.
26. Montpetit AJ, Alhareeri AA, Montpetit M, Starkweather AR, Elmore LW, Filler K, Mohanraj L, Burton CW, Menzies VS, Lyon DE, Jackson-Cook CK. 2014. Telomere length: A review of methods for measurement. Nurs Res 63(4):289-299.
27. Movérare-Skrtic S, Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Zetterberg H, Blennow K, Svensson J. 2012. Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimerés disease a pilot study. Exp Gerontol 47(2):179-182.
28. Olovnikov AM. 1973. A theory of marginotomy: The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theoret Biol 41:181-190.
29. Panossian LA, Porter VR, Valenzuela HG, Zhu X, Reback E, Masterman D, Cummings JL, Effros RB. 2003. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol Aging 24:77-84.
30. Plentz RR, Caselitz M, Bleck JS, Gebel M, Flemming P, Kubicka S, Manns MP, Rudolph KL. 2004. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology 40(1):80-86.
31. Presson AP, Partyka G, Jensen KM, Devine OJ, Rasmussen SA, McCAbe LL, McCabe ER. 2013. Current estimate of Down syndrome population prevalence in the United States. J Pediatr 163(4):1163-1168.
32. Puterman E, Lin J, Krauss J, Blackburn EH, Epel ES. 2015. Determinants of telomere attrition over 1 year in healthy older women: Stress and health behaviors matter. Mol Psychiatry 20(4):529-535.
33. Rumble V, Tetallack R, Hilbirch Simms CG, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masers CL. 1989. Amyloid A4 protein and its precursor in Down's syndrome and Alcheimer's disease. N Engl J Med 320(22):1446-1452.
34. Silverman W, Sckhupf N, Zigman W, Devenny D, Miezejeski C, Schkubert R, Ryan R. 2004. Dementia in adults with mental retardation: Assessment at a single point in time. Am J Ment Retard Mar 109(2):111-125.
35. Silverman WP, Zigman WB, Krinsky-McHale SJ, Ryan R, Schupf N. 2013. Intellectual disability, mild cognitive impairment and risk for dementia. J Policy Pract Intellect Disabil Sep 1 10(3): DOI: 10.1111/jppi.12042
36. Starkweather AR, Alhaeeri AA, Montpetit A, Brumelle J, Filler K, Montpetit M, Mohanral L, Lyon DE, Jackson-Cook CK. 2014. An integrative review of factors associated with telomere length and implications for biobehavioral research. Nurs Res 63(1):36-50.
37. Tanzi RE, Bird ED, Latt SA, Neve RL. 1987. The amyloid beta protein gene is not duplicated in brains from patients with Alzheimer's disease. Science 238(4827):666-669.
38. Watson JD. 1972. Origin of concataeric T4 DNA. Nat Biol 239:197-201.
39. Wegiel J, Kaczmarski W, Barua M, Kuchna I, Nowicki K, Wang K-C, Wegiel J, Yang S, Frackowiak J, Mazur-Koolecka B, Silverman W, Reisberg B, Monteiro I, de Leon M, Wisniewski T, Dalton A, Lau F, Hwang Y-W, Adayev T, Liu F, Iqbal K, Grundke-Iqbal I, Gong C-X. 2011. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat Tau protein in Down syndrome. J Neuropathol Exp Neurol 70:36-50.
40. Wenger W, Hansroth J, Shackelfor AM. 2014. Decreased telomere length in metapase and interphase cells from newborns with trisomy 21. Gene 542:87.
41. Wisniewski KE, Wisniewski HM, Wen GY. 1985. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17(3):268-282.
42. Zigman WB, Schupf N, Devenny DA, Zigman A, Silverman W. 2002. Incidence and temporal patterns of adaptive behavior change in adults with mental retardation. Am J Ment Retard 107(3):161-174.
43. Zigman WB. 2013. Atypical aging in Down syndrome. Dev Disabil Res Rev 18(1):51-67.